10 Panel Drug Test Screening Cup with Adulterants CLIA Waived 25/Box
Brand : Healgen Scientific
- Per Each:
- 25
Multi-Panel CLIA Waived Drug Screening Test Cup 10-Panel with Validity Tests Built-In
This High Quality CLIA Waived drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need of instrumentation. 
The Multi-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results
in 5 minutes. The cup is FDA Cleared and CLIA Waived. This non-branded cup is a fast visual, competitive panel immunoassay that can be used for the
simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- Health Canada Approved
- CE Marking - Meets all European Conformity Standards
- Sold in boxes of 25 tests
- Includes "Click Seal" in cap for improved leak resistance
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
Multi-Panel CLIA Waived Drug Test Package Insert
Multi-Panel CLIA Waived Drug Test Instruction Sheet
Ten Panel Configuration(s)
| Item Number | Drugs Tested | Adulterants Tested |
| HCDOA-3104A3 | AMP, BAR, BZO, COC, mAMP, MDMA, MTD, OPI, PCP, THC | OX, SG, pH |
| HCDOA-4104A3 | AMP, BAR, BZO, COC, mAMP, MTD, OPI, OXY, PCP, THC | OX, SG, pH |
SAMSHA Approved CLIA Waived Drug Panel Options
| Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
| Amphetamine | AMP | 1000 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
| Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
| Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
| Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
| Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
| Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | D,L- Methylenedioxy-methamphetamine |
| Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-Δ9-THC-9 COOH |
| Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
| Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
| Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
| Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
| Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
| Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
| Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
| Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
| * Detection times are not guaranteed. Reference configuration above for included drug panels. | |||||
Optional CLIA Waived Drug Panels (call 404-840-8900 for more information)
| Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
| Amphetamine | AMP | 500 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
| Cocaine | COC | 150 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
| EDDP | EDDP | 300 ng/ml | 1-4 hours | 2-4 days | 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine |
| Methamphetamine | mAMP / MET | 500 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
| * Detection times are not guaranteed. Reference configuration above for included drug panels. | |||||
TransMed Company offers the following optional Forensic Use Only (FUO) Panels: K2/Spice, EtG, Tramadol and Fenytanyl
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed
analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment
should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
